SEC Form 4 · accession 0001091818-26-000134
BIOFORCE NANOSCIENCES HOLDINGS, INC. · BFNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Merle Ferguson
Director
Period of report
Apr 20, 2026
Accepted (ET)
Sep 2, 2026 · 4:09 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001310488
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock; Par Value $0.001 | Apr 20, 2026 | G | 20,580,000 | $0.007 | A | 22,568,000 | D | |
| Common Stock; Par Value $0.001 | Apr 20, 2026 | G | 4,132,000 | $0.001 | A | 26,700,000 | D | |
| Common Stock; Par Value $0.001 | Apr 22, 2026 | S | 26,700,000 | $0.015 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.